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Abstract
Background: Social anxiety disorder (SAD) is highly prevalent among university students, but the majority of
affected students remain untreated. Internet- and mobile-based self-help interventions (IMIs) may be a promising
strategy to address this unmet need. This study aims to investigate the efficacy and cost-effectiveness of an
unguided internet-based treatment for SAD among university students. The intervention is optimized for the
treatment of university students and includes one module targeting fear of positive evaluations that is a neglected
aspect of SAD treatment.
Methods: The study is a two arm randomized controlled trial in which 200 university students with a primary
diagnosis of SAD will be assigned randomly to either a wait-list control group (WLC) or the intervention group (IG).
The intervention consists of 9 sessions of an internet-based cognitive-behavioral treatment, which also includes a
module on fear of positive evaluation (FPE). Guidance is delivered only on the basis of standardized automatic
messages, consisting of positive reinforcements for session completion, reminders, and motivational messages in
response to non-adherence. All participants will additionally have full access to treatment as usual. Diagnostic status
will be assessed through Structured Clinical Interviews for DSM Disorders (SCID). Assessments will be completed at
baseline, 10 weeks and 6-month follow-up. The primary outcome will be SAD symptoms at post-treatment,
assessed via the Social Phobia Scale (SPS) and the Social Interaction Anxiety Scale (SIAS). Secondary outcomes will
include diagnostic status, depression, quality of life and fear of positive evaluation. Cost-effectiveness and cost-utility
analyses will be evaluated from a societal and health provider perspective.
Discussion: Results of this study will contribute to growing evidence for the efficacy and cost-effectiveness of
unguided IMIs for the treatment of SAD in university students. Consequently, this trial may provide valuable
information for policy makers and clinicians regarding the allocation of limited treatment resources to such
interventions.
Trial registration: DRKS00011424 (German Clinical Trials Register (DRKS)) Registered 14/12/2016.
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Background
Anxiety disorders have the highest prevalence compared
to other mental health disorders, showing an estimated
lifetime prevalence of 10–22% in European Countries
[1]. Social anxiety disorder (SAD) is ranked as the third
most common anxiety disorder in Germany [2], and the
prevalence estimates of SAD in university students range
from 3.4% (12-month) in the United States [3] to 16.1%
(point-prevalence) in Sweden [4].
SAD among university students has been associated
with a number of adverse effects, including low quality
of life [5] and problems with identity formation [6],
increased consumption of alcohol [7] and high levels of
suicidal ideation [8]. Additionally, SAD-related emo-
tional distress causes dysfunctional avoidance strategies,
which are associated with underachievement and may
lead to premature drop out from university [4]. There-
fore, the economic burden extends beyond the direct
costs of treatment to indirect costs (e.g. low productivity,
increased number of sick days, lower qualification level
[9, 10]) and intangible costs (e.g. reduced quality of life,
social impairment). Thus, treatment of SAD is of
particular interest to the public healthcare system and
health services in and outside of university [11, 12],
especially as SAD may become a chronic condition when
left untreated [13].
Effective treatment options exist [14, 15], but are only
used by a small proportion of those in need [16, 17].
Reasons for low treatment rates include not only a
limited availability of trained clinicians but also other
barriers to help-seeking such as fear of stigmatization.
Fear of negative evaluation, the expectation that others
might judge one’s behavior or physical symptoms as
embarrassing or humiliating, [18, 19] is the key feature
of SAD. Hence, the nature of SAD is one major reason
which prevents university students from seeking profes-
sional advice [9, 20].
Internet- and mobile-based interventions are a prom-
ising strategy to reach underserved SAD populations. In
contrast to traditional face-to-face therapy IMIs are
immediately accessible, lack stigmatization, are more
flexible, anonymous, and initiated with minimal (or no)
human contact [21–23]. In addition, although the initial
costs of developing an IMI can be quite high, the low
marginal costs of providing IMIs to additional user are
assumed to lead to lower overall expenditures [24].
Moreover, IMIs are likely to reduce health care delivery
costs compared to face-to-face treatment, as IMIs
involve minimal or no contact with mental health care
specialists and also reduce travel costs.
A large number of studies have shown that IMIs can
be effective in the treatment of common mental
disorders [22]. The most recent systematic review on
IMIs for SAD showed a mean standardized effect size of
g = 0.84 [0.72–0.97] compared to untreated control
groups and g = 0.38 [0.13–0.62] compared to active
control conditions [25]. We are aware of only one small
study (n = 38) that evaluated a psychological internet
supported intervention for SAD in university students
[26]. This study assessed an internet-based self-help
intervention with minimal email contact to a psycho-
therapist with in vivo group exposure compared to no in
vivo group exposure. The intervention resulted in large
pre-post within-group effect-sizes for both groups. The
generalizability of these results are, however, limited due
to methodological shortcomings (e.g. small sample size).
In addition, the study did evaluate neither the
cost-effectiveness of the intervention nor the effects of
unguided self-help.
One of the major cost-drivers and potential barriers
for large-scale treatment dissemination is the provided
level of therapeutic guidance in IMIs. In a recent
meta-analysis guided IMIs yielded a mean average effect
of g = 0.87 [0.72–1.02] compared to passive control
conditions such as WLC (n = 11) [25]. The standardized
effect size of unguided IMIs was g = 0.78 [0.50–1.05]
compared to passive controls (n = 8). The effect sizes
(0.28–1.47) varied widely between unguided IMIs
[27–34], which makes it difficult to anticipate the ex-
pected effect size for future studies. We suspect that
the variance in effect sizes between studies could be
explained by methodological differences such as small
(n = 20–40) [27, 29–32] to moderate (n = 56–62) [28, 34]
sample sizes, different lengths of follow-ups (e.g. only
three studies evaluated long-term effects [27–29]) and
high dropout rates. Therefore, additional research is
needed to determine the efficacy of unguided
internet-based interventions in the treatment of SAD,
particularly among university students.
Although it is often assumed that IMIs tend to be
cost-effective, there is limited empirical evidence show-
ing the impact on health economic outcomes [35–37].
To the best of our knowledge, only three studies investi-
gated the cost-effectiveness of IMIs for SAD; all of these
studies evaluated a therapist guided IMI [38–40]. To
date, no study has investigated the cost-effectiveness of
an internet-based intervention in university students,
and no study has evaluated the health economic effects
of an unguided internet-based intervention for SAD.
Although the efficacy of Cognitive Behavioral Therapy
(CBT) in the treatment of SAD is well-documented,
there is still room for improvement. Recent findings
suggest not only fear of negative evaluations to be a cen-
tral feature of SAD, but also prove a strong link between
SAD and the fear of positive evaluation (FPE) [41, 42].
According to Weeks and Howell’s (2012) bivalent fear of
evaluation model of social phobia, fear of evaluation in
general is the core component of SAD, including the
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fear of negative (FNE) and positive evaluation [43]. The
function of FPE in SAD also has been discussed in the
context of evolutionary models of social anxiety [44].
Empirical evidence shows that FPE and FNE are related
but distinct factors contributing to SAD, with FPE
explaining a unique and independent proportion of vari-
ance in the fear of social interactions [45]. Even though
established treatments for SAD do not address FPE dir-
ectly, there is evidence that CBT can reduce FPE, albeit
with smaller effect sizes compared to FNE [42]. And, im-
portantly, neglecting FPE in SAD treatments may im-
pede treatment progress (e.g., when clients still feel
anxious after successful exposures that received positive
feedback) [46]. Specifically, people who endorse FPE do
not feel proud when making progress or achieving goals
and, paradoxically, often experience discomfort [41]. In
that sense, FPE often results in socially anxious people
avoiding social situations in which they are the focal
point (e.g., group work, presentations at university)
which prevents their exposure to positive social feedback
and safeguards their social status within the group [42,
47]. Although research has shown that FPE is responsive
to cognitive-behavioral therapy [48], no intervention has
systematically addressed this as a treatment component
of SAD.
The aim of this study will be to evaluate whether an
unguided internet-based intervention for SAD is effect-
ive in reducing social anxiety symptoms and other
secondary outcomes such as depression, fear of positive
evaluation, interpersonal problems and quality of life
when compared to a WLC in university students. Add-
itionally, cost-effectiveness analyses will be conducted
from societal and health provider perspective in order to
examine whether this internet-based intervention for
SAD represents good value for money.
This study is part of the recently launched Caring
Universities – the World Health Organization (WHO)
World Mental Health International College Student
(WMH-ICS) initiative (https://www.hcp.med.harvard.
edu/wmh/college_student_survey.php) [49, 50]. It is an
international initiative which aims to obtain accurate
cross-national data on the prevalence, and correlates of
mental disorders among university students throughout
the world, assess unmet needs for treatment, develop
practical methods to improve mental health intervention
utilization, and evaluate effective strategies for the pre-
vention and treatment of mental health disorders in uni-
versity students.
Methods
Study design
This study is a randomized-controlled trial in which the
assumed superiority of an internet-based intervention
for SAD is evaluated compared to a WLC. The
intervention group will receive the internet-based
self-help treatment for social anxiety and the control
group will obtain access to this intervention after 6
months. Both conditions have full access to university
and community treatment as usual.
Participants
We anticipate recruiting a total of N = 200 partici-
pants of which 100 participants will be assigned to
each of the two conditions. Participants will be re-
cruited in Germany, Austria and Switzerland. The re-
cruitment strategy consists of various components: a
study website, a promotional video, postings to Face-
book and Internet forums and an email with informa-
tion of the study sent to all German, Swiss and
Austrian university psychological counseling centers
and all students attending different universities based
in Ulm, FAU, Bern, Dresden, Hagen, and Vienna. The
study flow is illustrated in Fig. 1.
Inclusion criteria
Participants will be included if they
 are a student,
 are at least 18 years old,
 have internet access,
 have sufficient German language skills as assessed
via self-report (“Do you speak and understand
German?”),
 exceed predefined cut-off scores in the SPS or SIAS,
 fulfill the diagnostic criteria of SAD according to
DSM-IV assessed via a SCID-I diagnostic interview,
 have the ability to provide a written informed
consent.
Exclusion criteria
Participants will be excluded if they,
 show an acute suicidal risk according to the suicide
item of the Beck Depression Inventory II (BDI II)
(score > 1) or the diagnostic interview,
 have a history of psychotic or bipolar disorders,
 and are receiving psychotherapy at the time of
entering the study.
 Prescription medications for anxiety and depression
lead to an exclusion if the dosage was changed one
month before the beginning of the study.
Randomization
Two hundred participants will be randomly assigned.
The allocation list is produced by a random number
generator Randlist [9] which randomly allocates partici-
pants in a 1:1 ratio with a block size of 8 to either IMI
or WLC. The list is operated by an independent
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researcher not otherwise involved in the study. This re-
searcher has no information about the participants other
than the participants’s trial ID numbers and will
randomize the participants in the order of the incoming
informed consent form. During the randomization
process, the allocation will be concealed from partici-
pants and researchers involved in recruitment. Partici-
pants will not be blinded to study conditions.
Internet-based self-help intervention with an additional
session on fear of positive evaluation
The intervention is based on the well-established
cognitive-behavioral treatment of Clark and Wells (1995)
[51] and has been shown to be efficacious in several previ-
ous studies [27, 52–55]. It consists of nine text-based ses-
sions, various exercises (e.g. attention training) and diaries
(such as a diary to identify and question negative
thoughts). Participants are advised to complete one ses-
sion per week, review the exercises, and complete diaries.
The approximate time required to complete one session is
60min, and participants are encouraged to practice the
strategies in their daily life. An overview of the sessions is
summarized in Table 1. The original intervention was tai-
lored to the university setting, for example, by providing
case examples of socially anxious students.
An additional module in session 4 not part of the ori-
ginal Clark and Wells program targets FPE. FPE is defined
as discomfort and fear in reaction to positive feedback
from others. The module contains psychoeducational ma-
terial regarding the definition and etiology of FPE accord-
ing to the bivalent fear of evaluation model [43] and the
evolutionary model [44], as well as information on
FPE-related cognitive strategies such as the disqualifica-
tion of positive social outcomes (DPSO). A thought diary
is introduced to identify and modify FPE-related cogni-
tions, including perceived costs and advantages of positive
evaluation. Additionally, the module contains exercises
that aim at promoting self-compassion as well as the ex-
perience and acceptance of positive emotions which have
been linked to a decrease of FPE [56].
Although this is a therapeutically unguided self-help
intervention, guidance is provided via standardized
automatic messages aiming to promote adherence.
Adherence reminders follow procedures used in a
number of previously conducted studies [57–59]. They
consist of one positive reinforcement per session com-
pletion and one automatic reminder if participants do
not log into the platform for more than one week. These
automated reminders contain standardized personalized
motivational messages, which strengthen participants’
adherence to the intervention.
Table 1 Session content for the SAD internet-based self-help program
Session Intervention content
Session 1
Motivational enhancement
Reasons to initiate change, defining goals and recoding introspection
of difficult social situations with help of an anxiety protocol
Session 2
Psychoeducation
Information on SAD and maintaining factors such as negative thoughts,
safety behaviors and self-focused attention
Development of an individual model for SAD
Session 3
Cognitive restructuring
Identification and modification of negative thoughts (dysfunctional
assumptions) with the help of a thought diary
Session 4
Fear of positive (social) evaluation
Information about FPE (examples and explanatory models)
Identifying FPE using a diary
Recognizing the devaluation of own achievements, the benefit and the
risks of positive evaluation using a diary
Endorsing positive evaluations and emotions applying a
self-compassion-interventions
Session 5
Self-focused attention
Various exercises to reduce self-focused attention
Session 6
Behavioral experiments
Planning and conducting in-vivo exposures
Session 7
Summary and revision
Summary of the key elements of the training
Highlighting the importance of revising the exercises
(e.g. in-vivo exposure)
Session 8
Healthy lifestyle and problem solving
Information about healthy lifestyle (e.g. sports, nutrition)
Conveying problem solving skills
Session 9
Relapse prevention
Strategies to maintain the acquired skills
Preparing for possible relapses
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Procedure
Students who are interested in enrolling in the study will
contact the study team through a contact form from a
student mental health platform (i.e., on www.studicare.
com) or directly via email. If participants satisfy inclu-
sion criteria they will be randomly assigned to either the
IG or the WLC. Students who are assigned to the IG
can initiate the online-based self-help intervention im-
mediately after randomization. Students in the WLC will
receive access to the program six months after
randomization. The study includes three assessments:
both groups are assessed at baseline (t0), immediately
after completing the program (t1; 10 weeks) and at
follow-up six months after randomization (t2). The as-
sessment at t1 (10 weeks) is independent from treatment
completion. Treatment adherence will be monitored
after t1. Self-reported measures are collected using a se-
cure web-based assessment system (UNIPARK, 256-bit
encrypted [60]). This system allows for data validation
(range checks, double data entries) to improve data
quality. Additionally, participants’ SAD symptoms in IG
will be assessed weekly via the intervention platform.
The collected data will be stored securely.
Measurements
A detailed overview of all measures at baseline (t0),
10-week post-treatment (t1) and 6-month follow-up is
given in Table 2.
Primary outcome measures
Symptoms of SAD
The primary outcome is SAD symptoms. SAD symp-
toms will be measured with two widely used measures,
the Social Phobia Scale and the Social Interaction
Anxiety Scale (SPS & SIAS; [61]). These two self-report
questionnaires complement one another and are usually
administered together. The SIAS assesses more general
fears of social interaction (e.g., “I tense up if I meet an
acquaintance in the street”), while the SPS focuses on
fears of being judged by others during daily activities
(e.g., “I become anxious if I have to write in front of
others.”). Both scales consist of 20 items to be rated on a
5-point Likert scale (0= “not at all” to 4 = “ex-
tremely”). These two companion measures have been
found to be valid, reliable and useful for clinical and re-
search purposes [62]. Cronbach alphas for the SIAS and
SPS range from 0.90 to 0.94 [63].
Fig. 1 Study flow chart
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Secondary outcome and process measures
Diagnostic status
The diagnostic status will be assessed with the Struc-
tured Clinical Interview for DSM-IV (SCID-I [64]). The
interview will be conducted and recorded by trained
raters (clinical psychologists or graduate students in
psychology) via telephone at baseline and 6-months. The
raters are blind to the condition the participants are
assigned to. In order to ensure blinding, (a) participants
receive information on the importance of not informing
interviewers about the conditions they were assigned to,
(b) raters receive a written reminder to not ask the par-
ticipants for their randomization status, (c) written and
verbal reminders for the participants before the inter-
view; and (d) a documentation after the interview if the
rater is still blind to treatment condition. The inter-rater
reliability will be evaluated through a random selection
of 10% of recorded cases.
Beck depression inventory II
Depression severity will be assessed using the Beck
Depression Inventory II (BDI-II) [65]. The scale consists of
21 items each rated on a 4-point Likert-scale. Prior research
has shown high reliability and validity in SAD clients [27].
Brief symptom inventory
General psychopathology will be assessed using the Brief
Symptom inventory (BSI), which spans 9 dimensions,
including insecurity in social situations, anxiety, depres-
siveness and compulsivity [66]. The BSI assesses
symptoms within the past week and has shown robust
psychometric properties [67]. The Global Severity Index
(GSI), the overall mean score, will be reported.
Liebowitz social anxiety scale
The Liebowitz Social Anxiety Scale (LSAS) [68, 69] is a
self-report scale that assesses fear and avoidance in 24
different situations. Thirteen of the situations relate to
performance and the remaining items assess situations
within the context of social interactions. Prior research
has shown good to excellent reliability and validity
(Cronbach’s alphas ranging from 0.83 to 0.94) [68].
Inventory of interpersonal problems
Difficulties in interpersonal behavior and sources of rela-
tional distress will be assessed using the Inventory of
Interpersonal Problems (IIP-64) since they indicate
assertiveness and passivity of participants. The instru-
ment has eight dimensions and has shown adequate psy-
chometric properties (Cronbach’s alphas ranging from
0.71 to 0.82) [70, 71].
Fear of positive evaluation
Fear of positive social feedback will be assessed using
the Fear of Positive Evaluation Scale [72]. The FPES is a
Table 2 Measurements and time of assessment
Instrument Abbreviation Aim Time of assessment
t0 t1 t2
Clinician administered
Structured Clinical Interview for DSM-IV Axis I Disorders SCID-I DSM-IV Axis I disorders ✔ ✔
Self-report ratings
Primary Outcome Measure
Social Phobia Scalea SPS Symptoms of SAD ✔ ✔ ✔
Social Interaction Anxiety Scalea SIAS Symptoms of SAD ✔ ✔ ✔
Secondary Outcome Measure
Liebowitz Social Anxiety Scale LSAS-SR Social anxiety symptoms ✔ ✔ ✔
Beck Depression Inventory II BDI-II Symptoms of depression ✔ ✔ ✔
Brief Symptom Inventory BSI Psychiatric symptoms ✔ ✔ ✔
Inventory of Interpersonal Problems IIP-64 Interpersonal problems ✔ ✔ ✔
Fear of Positive Evaluation Scale FPES Fear of positive evaluation ✔ ✔ ✔
Disqualification of Positive Social Outcomes Scale DPSOS Fear of positive evaluation ✔ ✔ ✔
EuroQol (EQ-5D-5 L) EQ-5D-5 L Quality of life ✔ ✔ ✔
Assessment of Quality of Life (AQol) AQoL-8D Quality of life ✔ ✔ ✔
Client Satisfaction Questionnaire CSQ-8 Client satisfaction
Trimbos/iMTA Questionnaire for Costs associated with Psychiatric Illness TiC-P Cost-effectiveness ✔ ✔
Credibility Expectancy Questionnaire CEQ Treatment expectancy
t0 Baseline; t1 10 weeks; t2 6 months; Assessments ✔ = intervention and control group; = intervention group a process measures assessed every 2 weeks
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self-report measure consisting of 10 items and has
shown good psychometric properties in clinical and
healthy samples [48, 72].
The disqualification of positive social outcomes
(DPSO) is a cognitive strategy which has been linked to
FPE [43, 72]. This cognitive tendency is proposed to
serve as a mental safety behavior in the context of FPE
and will be measured using the Disqualification of
Positive Social Outcomes Scale (DPSOS) [73]). The
DPSOS is designed to measure the disqualification of
positive outcomes on two dimensions, other-oriented
attributions (e.g., “people will laugh at my jokes even if
they are not funny”) and self-oriented attributions that
refer directly to DPSO (e.g., “I frequently dismiss my
own social successes and accomplishments”).
Quality of life
The Assessment of Quality of Life (AQol) [74] and the
EuropeanQuality of Life 5 Dimensions 3 Level
(EQ-5D-5L) instrument [75, 76] will assess quality of life.
The AQol assesses eight dimensions (independent living,
pain, senses, mental health, happiness, coping, relation-
ships, self-worth) and allows for the calculation of separ-
ate sum scores for each dimension. The EQ-5D is a
widely applied, valid and reliable measurement of quality
of life. It consists of five items on a five-point Likert
scale related to mobility, self-care, common activities,
pain/discomfort and anxiety/depression. Additionally,
this measure contains a visual analogue scale (VAS) to
assess the respondent’s self-rated health status. Only the
AQoL will be used as a secondary outcome, the EQ-5D
will only be used for sensitivity analyses in the health
economic outcome evaluation.
Cost measures
The Trimbos and iMTA Treatment Inventory of Costs
in Patients with psychiatric disorders (TIC-P) [77] was
adapted for the application to the German health care
system and the specific target group. Direct medical
costs (e.g., drugs), direct non-medical costs (e.g., trans-
portation) and indirect costs (e.g., productivity losses)
[78] will be assessed over a period of the previous 3
months. A catalog of German unit costs [79] will be
used to calculate total health care costs on individual
basis assuming that the majority of participants will be
from Germany [80]. Indirect non-medical cost stemming
from productivity losses due to presenteeism and absen-
teeism costs will be assessed with specific modules of
the TiC-P. From a student’s perspective a monthly rate
that students are paid due to the German Federal Law
on Support in Education (BAföG) [81] is assumed cover-
ing the general cost for living and education in
Germany. The intervention costs are estimated at €150
($181) per participant. This tariff stems from a health
care provider (GET.ON Institute) that offers comparable
internet-based interventions. Including German VAT of
19%, interventions costs were €178.50.
Other measures
Other assessments will include demographic variables
(e.g., age, gender, student status, etc.). Moreover, a
version of the German Client Satisfaction Questionnaire
(CSQ-8) [82] that was adapted to the online training
context will assess the acceptance of internet-based in-
terventions and global client satisfaction on the inter-
vention [83]. Adherence to treatment will be evaluated
by completion rate and time spent in intervention. The
6-item German version of the Credibility Expectancy
Questionnaire (CEQ) [84] assesses the intervention’s
credibility and outcome expectancies. Additionally,
credit points based on the European Credit Transfer
System (ECTS) [85] are assessed to evaluate the reduced
academic productivity.
Process measures
Participants in the active conditions will be asked to rate
their symptoms of SAD every two weeks (SPS & SIAS)
in order to detect change in social phobic symptoms
during the intervention.
Power and sample size calculation
The study is powered to detect small to medium effect
sizes of d = 0.4. The intended sample size of 200 partici-
pants will provide sufficient power to detect a significant
standardized effect size (Cohen’s d) of 0.4 on the primary
outcome variable (symptoms of SAD via SPS and SIAS)
between the two conditions. The software Gpower [86]
was used to calculate the sample size of n = 100 per
group given a Bonferroni-adjusted (due to multiple test-
ing) alpha error level of 0.025 for a one-sided test, a stat-
istical power of 0.80 and an effects size of d = 0.4.
Analysis
Analyses will be conducted and reported according to
the Consolidated Standards of Reporting Trials
(CONSORT) statement [87]. The results will be dissemi-
nated in peer-reviewed scientific journals. The deperso-
nalized data will be analyzed based on the
intention-to-treat principle. Missing data will be handled
using multiple imputations with 10 estimations per
missing value following recommendations of Little and
Rubin [88] and Schafer [89]. Differences in continuous
outcomes between the groups will be analyzed using
analysis of covariance (ANCOVA), with pre-scores as a
covariate and the post-scores as the dependent variable.
Possible confounders (e.g. former use of psychotherapy)
will be assessed and included as covariates if they should
be associated with changes in the primary outcome. We
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will compute standardized effect sizes (Cohen’s d includ-
ing the 95% confidence intervals for all effect sizes). We
will also test differences in treatment response rates
(50% relative symptom reduction), numbers of partici-
pants displaying reliable change (according to Jacobson
and Truax [90]) as well as differences in symptom de-
terioration rates. Effect sizes between groups of dichot-
omous outcome variables will be expressed as
number needed to treat and its associated 95% confi-
dence intervals. All reported p-values are (one-sided) at
a significance level of 0.025 for the primary outcomes
and 0.05 for the secondary outcomes.
Moderators of the outcome will be analyzed on an
exploratory basis using regression analyses, as well as
region of significance procedures [91], in case of signifi-
cant findings. Baseline variables considered for moder-
ator analyses include: Sociodemographic and study-
related characteristics (e.g. age, gender, nationality,
full-time versus part-time students, study major, number
of semesters on leave, number of semesters in total,
ECTS points), baseline severity of social phobia (SIAS,
SPS), depressive (BDI-II) and general psychopathological
symptoms (BSI), interpersonal problems (IIP), fear of
positive evaluations (FPE), health-related quality of life
(AQoL), generalized vs. specific SAD, concurrent use of
psychotropic drugs, prior mental health treatment,
perceived treatment credibility (CEQ), comorbid depres-
sive disorders (SCID), number of comorbid disorders
(SCID), age of onset (SCID). Moderator analyses will not
be adjusted for multiple testing, as the aim is to generate
hypotheses to be tested in future confirmative studies.
All directional hypotheses are tested one-sided, bidirec-
tional hypotheses two sided.
Economic evaluation
We will perform an economic evaluation from the
societal and health provider perspectives that include all
relevant costs and outcomes. A cost-effectiveness
analysis as well as a cost-utility analysis will be con-
ducted following guidelines from the International Soci-
ety for Pharmacoeconomics and Outcomes Research
(ISPOR) Good Research Practices Task Force Report and
the recommendations of the Consolidated Health Eco-
nomic Evaluation Reporting Standard (CHEERS) [92,
93]. In the cost-effectiveness analyses, symptom-free sta-
tus via SPS and SIAS will be used as clinical outcome.
For cost-utility analyses, quality-adjusted life years
(QALYs) will be calculated based on the AQOL-8D.
EQ-5D-5L will be used only in sensitivity analyses. We
will compare both groups in terms of incremental costs
and incremental effects, by calculating the incremental
cost-effectiveness ratio (ICER). We will use bootstrap-
ping (N = 5000) and 95% confidence intervals in percen-
tiles to test the robustness of the ICER and to quantify
the uncertainty surrounding the ratios. The results will
be shown in a cost-effectiveness plane and in a
cost-effective acceptability curve. Additionally, the ro-
bustness of the base-case findings will be tested with a
multi-way sensitivity analysis (i.e. ± 50% intervention
costs, costs outliers, EQ-5D-5L as alternative instrument
to calculate QALYs).
Discussion
SAD is a highly prevalent mental health disorder, also
among university students. Affected students suffer from
lower quality of life, high burden of psychological strain
and reduced academic functioning. Internet-based
interventions represent a low-threshold, easily accessible,
and flexible treatment which may help to overcome the
low utilization rates of those in need.
Within this study we intend to extend the evidence of
internet-based self-help for SAD regarding efficacy and
cost-effectiveness. Particularly, we want to strengthen the
evidence of unguided treatments, since the question
how much support is needed remains unanswered given
prior mixed results. On the one hand, results from two
meta-analyses [94, 95] found self-help programs with
support to be more effective and with lower attrition
rates compared to no support. Whereas a recent
meta-analysis on internet-based guided cognitive behav-
ioral interventions for anxiety disorders in general did
not find such differences, indicating that effects between
current guided and unguided treatments for anxiety
might be smaller than previously anticipated [25].
There may be several other factors such as the inten-
sity of screening procedures [52], the length, structure
and comprehensiveness of the self-help program itself
[96], the extent of support needed depending on the dis-
order [95] as well as human substitutes such as auto-
mated reminders [97], which systematically confound
whether guided interventions lead to superior results
compared to unguided interventions [98].
This study will have three noteworthy limitations.
First, if this study demonstrates clinically relevant effects
for unguided self-help for SAD, it has to be taken into
account that this evidence will be based on an RCT,
which is characterized by a highly structured participa-
tion and research attention. This is usually not the case
when self-help interventions are offered in routine care.
Since the securing of commitment represents an
adherence-promoting element in self-help interventions,
it has been argued that effect sizes of pure self-guided
interventions found in RCTs are significantly overesti-
mated for what can be expected in routine care [99],
when no additional measures to increase adherence are
applied. Hence, in order to achieve similar effects out-
side laboratory conditions, a clear concept for ensuring
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adherence through minimal guidance from a profes-
sional or lay health worker seems favorable.
Second, we will employ an open recruitment strategy
in the general student population. Such a procedure
mimics a public health approach of student mental
health treatment barriers of face-to-face treatment
pathways. However, results need to be interpreted cau-
tiously in such a context and may not generalize to clas-
sical routine face-to-face clinical practice pathways. A
previous study has found that patients undergoing
internet-based treatment resembled national general
samples more closely than samples from routine
face-to-face mental health care [100].
Third, the cost assessment is based on a self-report
instrument and it may be argued that self-report data
are potentially less accurate compared to data col-
lected directly from public registers. However, com-
parative studies of self-report questionnaires and
diaries have found an acceptable comparability [101].
The remaining risk, however, is likely to be equal
across treatments, making it unlikely that it will result
in a bias between groups.
Conclusion
To the best of our knowledge, this study will have the
largest unguided RCT intervention group recruited for
SAD treatment so far [15, 102]. This study will contrib-
ute to the evidence for the efficacy, cost-effectiveness
and moderators of unguided internet-based self-help for
social phobia in university students. If successful, this
intervention would facilitate the adequate allocation of
scarce resources and will provide valuable information
of a public health approach of SAD treatment. When
implemented on large scale, such interventions might
help to reduce the immense burden associated with
SAD in university students.
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